Cargando…
Pharmacological Treatments against COVID-19 in Pregnant Women
The recent respiratory virus known as SARS-CoV-2 has caused millions of deaths worldwide, causing great uncertainty due to the lack of a specific treatment, which has been mitigated by the use of various drugs traditionally used against other types of pathologies. Pregnancy presents special physiolo...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584594/ https://www.ncbi.nlm.nih.gov/pubmed/34768416 http://dx.doi.org/10.3390/jcm10214896 |
_version_ | 1784597487230648320 |
---|---|
author | Arco-Torres, Ana Cortés-Martín, Jonathan Tovar-Gálvez, María Isabel Montiel-Troya, María Riquelme-Gallego, Blanca Rodríguez-Blanque, Raquel |
author_facet | Arco-Torres, Ana Cortés-Martín, Jonathan Tovar-Gálvez, María Isabel Montiel-Troya, María Riquelme-Gallego, Blanca Rodríguez-Blanque, Raquel |
author_sort | Arco-Torres, Ana |
collection | PubMed |
description | The recent respiratory virus known as SARS-CoV-2 has caused millions of deaths worldwide, causing great uncertainty due to the lack of a specific treatment, which has been mitigated by the use of various drugs traditionally used against other types of pathologies. Pregnancy presents special physiological conditions that expose the pregnant woman and the foetus to greater risk. Pregnant women are often excluded from trials due to possible risk of toxicity or side effects, resulting in a lack of knowledge about the use of drugs and treatments during pregnancy. The main objective of this review was to compile existing knowledge about currently available drug treatments for COVID-19 in pregnant women. The review report met the criteria of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) review protocol and was registered with the registration number CRD42021251036. The electronic databases searched were Scopus, PubMed, CINAHL and SciELO. Finally, 22 articles were included, resulting in an analysis of drugs with an acceptable safety profile in the treatment of pregnant women with COVID-19. |
format | Online Article Text |
id | pubmed-8584594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85845942021-11-12 Pharmacological Treatments against COVID-19 in Pregnant Women Arco-Torres, Ana Cortés-Martín, Jonathan Tovar-Gálvez, María Isabel Montiel-Troya, María Riquelme-Gallego, Blanca Rodríguez-Blanque, Raquel J Clin Med Review The recent respiratory virus known as SARS-CoV-2 has caused millions of deaths worldwide, causing great uncertainty due to the lack of a specific treatment, which has been mitigated by the use of various drugs traditionally used against other types of pathologies. Pregnancy presents special physiological conditions that expose the pregnant woman and the foetus to greater risk. Pregnant women are often excluded from trials due to possible risk of toxicity or side effects, resulting in a lack of knowledge about the use of drugs and treatments during pregnancy. The main objective of this review was to compile existing knowledge about currently available drug treatments for COVID-19 in pregnant women. The review report met the criteria of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) review protocol and was registered with the registration number CRD42021251036. The electronic databases searched were Scopus, PubMed, CINAHL and SciELO. Finally, 22 articles were included, resulting in an analysis of drugs with an acceptable safety profile in the treatment of pregnant women with COVID-19. MDPI 2021-10-24 /pmc/articles/PMC8584594/ /pubmed/34768416 http://dx.doi.org/10.3390/jcm10214896 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Arco-Torres, Ana Cortés-Martín, Jonathan Tovar-Gálvez, María Isabel Montiel-Troya, María Riquelme-Gallego, Blanca Rodríguez-Blanque, Raquel Pharmacological Treatments against COVID-19 in Pregnant Women |
title | Pharmacological Treatments against COVID-19 in Pregnant Women |
title_full | Pharmacological Treatments against COVID-19 in Pregnant Women |
title_fullStr | Pharmacological Treatments against COVID-19 in Pregnant Women |
title_full_unstemmed | Pharmacological Treatments against COVID-19 in Pregnant Women |
title_short | Pharmacological Treatments against COVID-19 in Pregnant Women |
title_sort | pharmacological treatments against covid-19 in pregnant women |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584594/ https://www.ncbi.nlm.nih.gov/pubmed/34768416 http://dx.doi.org/10.3390/jcm10214896 |
work_keys_str_mv | AT arcotorresana pharmacologicaltreatmentsagainstcovid19inpregnantwomen AT cortesmartinjonathan pharmacologicaltreatmentsagainstcovid19inpregnantwomen AT tovargalvezmariaisabel pharmacologicaltreatmentsagainstcovid19inpregnantwomen AT montieltroyamaria pharmacologicaltreatmentsagainstcovid19inpregnantwomen AT riquelmegallegoblanca pharmacologicaltreatmentsagainstcovid19inpregnantwomen AT rodriguezblanqueraquel pharmacologicaltreatmentsagainstcovid19inpregnantwomen |